The Vancouver-based biotech said Eli Lilly has entered into a purchase agreement with the U.S. government to supply up to 600,000 doses of bebtelovimab for at least US$720 million. The U.S. Food and Drug Administration authorized the antibody for emergency use Friday. (The Logic)
Skip to content
The Vancouver-based biotech said Eli Lilly has entered into a purchase agreement with the U.S. government to supply up to 600,000 doses of bebtelovimab for at least US$720 million. The U.S. Food and Drug Administration authorized the antibody for emergency use Friday. (The Logic)
Talking point: Eli Lilly partnered with AbCellera, using its technology to develop bebtelovimab and another COVID-19 therapy, bamlanivimab. The FDA recently limited the use of a combination treatment that uses the latter after it proved less effective against the Omicron variant, but preclinical data shows bebtelovimab is effective in fighting Omicron. AbCellera receives a royalty from partners’ sales of products it helps develop. In the nine months ending Sept. 30, 2021, AbCellera earned nearly $192.9 million in revenue from sales of bamlanivimab, according to its most recent quarterly report.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
Commentary
Carmichael: If an AI jobs apocalypse is coming, we’re not seeing it in the data
Briefing
Anthropic says world needs option to slow AI development, as models learn to self-improve
Ottawa taps the brakes on efforts to speed up project permitting
Kevin O’Leary scales back Wonder Valley Utah plans after objections from a key state legislator
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
